在肌痛性脑筋炎/慢性疲劳综合征中免疫学患者分层
Johanna Rohrhofer1, Lisa Hauser1, Lisa Lettenmaier1
1Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Journal of clinical medicine
|January 11, 2024
概括
肌痛性脑筋炎/慢性疲劳综合征 (ME/CFS) 涉及免疫和肠道问题. 患者的分层揭示了不同的子组,这对于开发针对性治疗这种复杂疾病至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 病理生理学 病理生理学
背景情况:
- 肌痛性脑筋炎/慢性疲劳综合征 (ME/CFS) 是一种复杂,普遍的疾病,原因不明.
- 关键症状包括疲劳,运动后不适 (PEM) 和认知问题,通常伴有免疫和胃肠道障碍.
研究的目的:
- 调查ME/CFS患者免疫特征与肠道屏障功能之间的联系.
- 通过患者分层,在ME/CFS中识别出不同的病理生理模式.
主要方法:
- 收集了ME/CFS患者的血清和血样本.
- 使用ELISA评估炎症调解剂和肠道屏障完整性标记物.
- 将患者分为免疫缺陷和非免疫缺陷组.
主要成果:
- 免疫缺陷ME/CFS患者的补充C4a水平降低,表明先天免疫失调.
- 非免疫缺陷的ME/CFS患者表现出粘膜屏障泄漏,由升高的脂多糖结合蛋白 (LBP) 证明.
- 患者分层揭示了两个不同的亚组,具有不同的病理生理学特征.
结论:
- 基于免疫能力的ME/CFS患者分层对于了解疾病机制至关重要.
- 识别具有独特免疫和肠道特征的不同亚组是开发有效ME/CFS治疗方法的关键.
- 需要进一步的研究来确定ME/CFS的致病性治疗方法,解决其显著的健康和社会经济影响.
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
847
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
847
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K